A detailed history of Ziegler Capital Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Ziegler Capital Management, LLC holds 6,827 shares of REGN stock, worth $5.04 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
6,827
Previous 6,985 2.26%
Holding current value
$5.04 Million
Previous $6.13 Million 7.11%
% of portfolio
0.23%
Previous 0.28%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$902.69 - $993.35 $142,625 - $156,949
-158 Reduced 2.26%
6,827 $6.57 Million
Q4 2023

Jan 11, 2024

SELL
$775.18 - $881.7 $234,104 - $266,273
-302 Reduced 4.14%
6,985 $6.13 Million
Q3 2023

Oct 16, 2023

SELL
$692.45 - $844.37 $229,893 - $280,330
-332 Reduced 4.36%
7,287 $6 Million
Q2 2023

Jul 25, 2023

SELL
$700.03 - $830.35 $310,813 - $368,675
-444 Reduced 5.51%
7,619 $5.47 Million
Q1 2023

May 04, 2023

SELL
$680.49 - $826.97 $89,824 - $109,160
-132 Reduced 1.61%
8,063 $6.63 Million
Q4 2022

Jan 24, 2023

SELL
$705.89 - $766.39 $96,001 - $104,229
-136 Reduced 1.63%
8,195 $0
Q3 2022

Oct 25, 2022

SELL
$573.97 - $724.32 $1.34 Million - $1.69 Million
-2,337 Reduced 21.91%
8,331 $5.74 Million
Q2 2022

Jul 21, 2022

SELL
$548.35 - $738.84 $169,440 - $228,301
-309 Reduced 2.81%
10,668 $6.31 Million
Q1 2022

May 04, 2022

SELL
$595.12 - $698.43 $443,364 - $520,330
-745 Reduced 6.36%
10,977 $7.67 Million
Q4 2021

Feb 09, 2022

SELL
$543.48 - $670.97 $303,261 - $374,401
-558 Reduced 4.54%
11,722 $7.4 Million
Q3 2021

Oct 27, 2021

SELL
$574.03 - $680.96 $127,434 - $151,173
-222 Reduced 1.78%
12,280 $7.43 Million
Q2 2021

Jul 21, 2021

SELL
$472.8 - $558.54 $237,345 - $280,387
-502 Reduced 3.86%
12,502 $6.98 Million
Q1 2021

Apr 29, 2021

BUY
$446.73 - $548.2 $5.61 Million - $6.88 Million
12,558 Added 2815.7%
13,004 $6.15 Million
Q4 2020

Feb 05, 2021

BUY
$478.3 - $607.98 $213,321 - $271,159
446 New
446 $215,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Ziegler Capital Management, LLC Portfolio

Follow Ziegler Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ziegler Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ziegler Capital Management, LLC with notifications on news.